# A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

> **NCT00000793** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 240 (—)

## Conditions studied

- HIV Infections
- Peripheral Nervous System Disease

## Interventions

- **DRUG:** Mexiletine hydrochloride
- **DRUG:** Benztropine mesylate
- **DRUG:** Amitriptyline hydrochloride

## Key facts

- **NCT ID:** NCT00000793
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1997-10
- **Target enrollment:** 240 (—)
- **Last updated:** 2021-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000793, "A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00000793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*